Medicus Pharma earnings were -$47.3M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest MDCX earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$15.1M, down 28% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MDCX reported annual earnings of -$47.3M, with 323.8% growth.
On MDCX's earnings call on Invalid Date, Medicus Pharma (NASDAQ: MDCX) reported Q4 2025 earnings per share (EPS) of -$0.83, up 159.38% year over year. Total MDCX earnings for the quarter were -$15.07 million. In the same quarter last year, Medicus Pharma's earnings per share (EPS) was -$0.32.
As of the last Medicus Pharma earnings report, Medicus Pharma is currently losing money. Medicus Pharma's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$35.44 million, a 217.73% increase year over year.
What was MDCX's earnings growth in the past year?
As of Medicus Pharma's earnings date in Invalid Date, Medicus Pharma's earnings has grown year over year. MDCX earnings in the past year totalled -$47.28 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.